Correlation Between Visa and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and TG Therapeutics, you can compare the effects of market volatilities on Visa and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and TG Therapeutics.

Diversification Opportunities for Visa and TG Therapeutics

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Visa and TGTX is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Visa i.e., Visa and TG Therapeutics go up and down completely randomly.

Pair Corralation between Visa and TG Therapeutics

Taking into account the 90-day investment horizon Visa is expected to generate 4.91 times less return on investment than TG Therapeutics. But when comparing it to its historical volatility, Visa Class A is 5.37 times less risky than TG Therapeutics. It trades about 0.09 of its potential returns per unit of risk. TG Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  831.00  in TG Therapeutics on August 28, 2024 and sell it today you would earn a total of  2,630  from holding TG Therapeutics or generate 316.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Visa Class A  vs.  TG Therapeutics

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
TG Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Visa and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and TG Therapeutics

The main advantage of trading using opposite Visa and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Visa Class A and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios